HOME ABOUT CONTACT PREVIOUS ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Intelligent Sensor Informs You to Change a Diaper via SMS       » University of Manchester & A*STAR ongoing partnership- Joint PhD programme       » Philippines Healthcare & New Digital Platform, MyDoc.       » Tapping on ASEAN'S Healthcare Opportunities through Singapore       » ASEAN: The New Playing Field for Global Medical Device Companies       » The Burden of Great Potential: the ASEAN Economic Community & Biopharmaceuticals       » When there is no Queen in the house, Asian Hive Bees Avoid Risky Foraging for Reproduction       » XELJANZTM (Tofacitinib Citrate), A new class of treatment for Rheumatoid Arthritis Approved in Singapore      
EYE ON CHINA
China National Genebank and Smithsonian’s National Museum of Natural History collaborate on biobanking to advance biodiversity research
China National Genebank (Shenzhen), also referred to as “CNGB-Shenzhen”, and National Museum of Natural History (NMNH), U.S.A. jointly announced that they have reached a strategic agreement to promote biorepository and genomics research, as well as to enhance the mutual exchanges of experience in resource collection and sharing, infrastructure construction and information management.

Biodiversity is increasingly recognized as critical to human life, from genetic diversity within a species to diversity within entire regions or ecosystems. However, many species are more threatened than ever by urbanization, global deforestation, climate change, industrial agricultural expansion and other human activities. To achieve the stable and sustainable development, it is important for all of us to preserve the biodiversity of life on earth for future research and discovery.

As a leading collections institution and the most visited natural history museum in the world, NMNH’s collections total over 126 million specimens of plants, animals, fossils, minerals, rocks, meteorites, and human cultural artifacts. It also has traditionally taken on the role of supporting research through their collections, making them the natural leaders in the support of genomic research, such as the collaborative effort - Global Genome Initiative (GGI) - to preserve the genomic diversity of life on earth.

Under the agreement with NMNH, CNGB-Shenzhen established a Biological Resource Bank, an Information Database and a Network domestically and across the globe providing a powerful support for Omics-related scientific research and applications to promote the goals of biodiversity protection and sustainable development. With the approval and support of China National Development and Reform Commission and other national commissions, CNGB-Shenzhen was established in 2011, based on BGI-Shenzhen’s robust technology platforms and computational infrastructure to analyze and store the massive OMICS data. By January 2013, CNGB-Shenzhen has collected more than one million biological samples including tissues, cells, blood, bodily fluids etc.

The partnership between CNGB-Shenzhen and NMNH will utilize both their expertise so as to better improve the biodiversity preservation and research. Under the agreement, two parties also will conduct scientific collaborations on the establishment of laboratory and data standards, data management, and professional training and education. Moreover, CNGB-Shenzhen will be responsible for providing high-throughput digitalization and informatics analysis, and management for advancing applications.

Dr. Jonathan Coddington, Associate Director of Research and Collections at NMNH, said, “The Global Genome Initiative is a Smithsonian-led effort to preserve the genomic diversity of life on Earth. As part of this program, NMNH is extremely pleased to partner with the China National Gene Bank (Shenzhen) to preserve and study comprehensive samples of Earth’s genomic diversity. Together, we intend to support biodiversity genome science, to dramatically advance collection-based bioinformatics, to build the virtual, global biorepository, and to train the next generation of genomic scientists. We believe synoptic collections of quality genome samples will be an essential science infrastructure to address pressing human needs.”

Dr. Yong Zhang, Director of CNGB-Shenzhen, said, “It provides an unprecedented collaborative opportunity for NMNH and CNGB-Shenzhen to accelerate their growth, execute their global partnering strategy and support biodiversity research and development efforts. Combining two organizations’ world-leading expertise and extensive research experience in these fields, I believe we could seek more innovative solutions to better face the challenges of medical, environmental, energy, security, biodiversity protection and agricultural problems.”

Click here for the complete issue.

EDITORS' CHOICE  

Credits to: American Chemical Society
COLUMNS  

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy